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August 2011594 AbstractsP  .05). Human vein grafts (age 84-1330 days) showed significantly
increased HSP75 expression in the intima and media as compared to
controls (P  .05). Early vein grafts (365 days, n  3) may have greater
relative HSP75 expression than late vein grafts (365 days; n  9)
(ANOVA; P  .05). Both saphenous veins and human vein grafts had
positive staining for HSP90 and weaker staining for HSP90	 in the intima
and media.
Conclusions: Upregulation of the mitochondrial chaperone protein
HSP75 after venous arterialization may promote a state of relative apoptosis-
resistance within VSMC in the healing graft wall. Further studies are
underway to determine the specific role of these proteins in vein graft
remodeling.
Vasospasm as a Novel Mechanism to Explain Claudication in Female
Athletes with External Iliac Arterial Endofibrosis
Sherene Shalhub, MD, R. Eugene Zierler, Watson Smith, Kari Olmsted, and
Alexander W. Clowes, MD, Department of Surgery, Division of Vascular
Surgery, University of Washington, Seattle, Wash.
Objective: External iliac arterial endofibrosis (EIAE) is rare and has
been described primarily in endurance male cyclists. Clinically it presents as
claudication during maximal exercise with quick resolution postexercise.
Most patients are found to have fibrotic changes within the external iliac
artery (EIA). We describe our experience with EIAE and propose a hypoth-
esis for the mechanism involved.
Methods: This was a retrospective review of athletes who presented
with symptomatic EIAE requiring an operative repair between 2001 and
2010. Data collected included demographic information, initial presenta-
tion, type of exercise, method of repair, and long-term outcome. Diagnostic
studies consisted of duplex scan evaluation, modified exercise treadmill test,
and angiography.
Results: Seven patients, all female, presented with symptomatic EIAE.
All were endurance athletes (2 cyclists, 1 runner, 4 both cyclists and
runners). Median age at presentation was 42.5 years (range, 39-60 years).
Median duration of symptoms was 5.5 years (range, 2-15 years). Two
patients had bilateral EIAE. Diagnosis was confirmed with an exercise
treadmill test modified to accommodate the high level of conditioning these
patients exhibited and unmask the claudication. In 2 cases, there was marked
EIA vasospasm noted postexercise by duplex scanning. All cases were treated
by EIA vein patch angioplasty. Follow-up ranged from 1 to 10 years. All had
a normal modified exercise treadmill test and resumed their athletic activities
postoperatively. In 2 cases, there was a recurrence of symptoms associated
with vasospasm in the unpatched EIA segments. In 1 case, there was onset of
claudication and documented postexercise vasospasm of the EIA in the
contralateral leg.
Conclusions: This is the largest reported series of female endurance
athletes with EIAE and highlights a possible mechanism to explain this
disease entity as a pathologic response to exercise-induced high blood
flow leading to EIA vasospasm, not vasodilation. This suggests that
repetitive injury leads to endothelial dysfunction of the regenerated EIA
endothelium. We recommend vein patch angioplasty as a durable repair
for this condition.
Increased Transfusion of Autologous Blood but not Plasma is Associ-
ated with Improved Survival in Ruptured Abdominal Aortic Aneurysm
David S. Kauvar, MD,a,b Mark R. Sarfati, MD,a and Larry W. Kraiss, MD,a
aDepartment of Vascular Surgery, University of Utah, Salt Lake City, Utah;
and bUniformed Services University of the Health Sciences, Bethesda, Md.
Objectives: The resuscitation of ruptured abdominal aortic aneurysm
(rAAA) patients has not been well-studied and the potential benefit of
autotransfusion (AT) is unknown. Increased use of plasma (fresh frozen
plasma [FFP]) is associated with decreased mortality in trauma patients and
may improve rAAA mortality. We explored the influence of AT and FFP
resuscitation on mortality in massively transfused (MT) patients with rAAA.
Methods: A single-center review of the medical records of patients
with rAAA from April 1989 to October 2009 was undertaken. Clinical data
and outcomes were studied. Operative and anesthesia records were queried
for intraoperative transfusion totals, MT was defined as 10 units of red
blood cells (RBCs) inclusive of AT units.
Results: One hundred fifty-one rAAAs were identified, 89 (60%)
received MT. In-hospital mortality was 44%. Univariates predictive of
mortality included increased age, preoperative hypotension, operative
blood loss, and crystalloid, RBC, and FFP volume. Eighty-five patients
received AT, with an increased ratio of AT: packed red blood cell (PRBC)
units associated with survival. Mortality was 34% with AT: PRBC 1
(HIGH AT) and 55% with AT: PRBC less than 1 (LOW AT, P  .03).
On multivariate analysis, age 74 (P  .03), preoperative systolic blood
pressure (SBP) 90 mm Hg (P  .06), blood loss 6L (P  .06), and
LOW AT (P  .02) independently predicted mortality. Mean RBC: FFP
ratios were similar in those that died (2.7) and lived (2.9; P .66). RBC:
FFP2 (HIGH FFP) was present in 38 (43%) patients, with mortality of
a
m9%. RBC: FFP less than 2 (LOW FFP) had 40% mortality (P  .39).
ver time, RBC: FFP ratios decreased from 3.6 (1989-1999) to 2.2
2000-2009; P  .001), but the more liberal use of FFP was not
ssociated with decreased mortality (47% vs 41%; P  .56). AT: PRBC
atios were stable over time (1.4-1.2; P  .18).
Conclusion: Greater use of AT but not of FFP was associated with
urvival in massively transfused patients with rAAA. We did not see a
ortality benefit with increased FFP, but few patients had high FFP trans-
usion ratios. Further study to identify patients with rAAA at risk for massive
ransfusion should be undertaken and a potentially greater role for AT in
AAA resuscitation investigated.
he Impact and Outcomes of Establishing an Integrated Interdisci-
linary Team to Care for Patients with Diabetic Foot Ulcers
avid G. Armstrong, DPM,a Matthew L. White, MD,b Manish Bharara,
hD,a Brian Lepow, DPM,a Kaoru R. Goshima, MD,a,b Daniel M. Ihnat,
D,c John D. Hughes, MD,a,b Sugam Bhatnagar, MBBS,a Timothy Fisher,
PM,a and Joseph L. Mills, Sr, MD,a,b aSouthern Arizona Limb Salvage
lliance (SALSA), Department of Surgery, bVascular and Endovascular
urgery, University of Arizona, Tucson, Ariz; and cthe Division of
ascular Surgery, Department of Surgery, University of Utah, Salt Lake
ity, Utah.
Objective: The purpose of this study was to quantify the impact of an
ntegrated diabetic foot surgical service on outcomes.
Methods: We abstracted registry data from 48 consecutive months at a
ingle institution, evaluating all patients with diabetic foot complications
equiring foot surgery or vascular intervention. We compared outcomes in
he 24 months before and after integrating podiatric surgery with a vascular
urgical limb-salvage service.
Results: The service performed 2923 operations; 790 operations
27.0%) were related to the treatment of diabetic foot complications in 374
atients. Of these, 502 operations were classified as nonvascular diabetic foot
urgery and 288 were vascular interventions. Overall, one third of patients
equired vascular intervention, initially endovascular in 86.5% of patients.
onversion to open bypass was required in 29.2% of these patients, more
han double the revision rate of those receiving open bypass first (13.1%).
fter team integration, vascular reconstructions increased 44.2%. This in-
rease held true for both endovascular (26.7% increase) and open interven-
ions (88.2% increase), with a trend toward more infrageniculate vascular
rocedures (43.2% vs 57.7%; P  .02; odds ratio [OR]  1.8). After team
ntegration, the percentage of urgent operations was significantly reduced
74.4% vs 51.8%; P .0001; OR 2.7), and the high/low amputation ratio
ecreased from 0.34 to 0.26, (P  .0001) due to an increase in midfoot
mputations (6.7% vs 11.6%; P .08; OR 1.8). Below knee amputations
BKAs) were reduced 45.7% with a relatively stable above knee/below knee
mputation (AKA/BKA) ratio (0.73-0.81).
Conclusions: Creation of an interdisciplinary vascular and podiatric
urgical team significantly impacts surgery type and volume. Significantly
ore nonurgent operations are performed with a decrease in the high/low
mputation ratio. Vascular surgery volume is significantly increased, espe-
ially with regard to open infrageniculate procedures. While endovascular
rocedures have become increasingly applicable, open bypass remains criti-
al to success.
perative Management of Neurogenic Thoracic Outlet Syndrome in
he Adolescent
esley K. Lew, MD, Jessica O’Connell, MD, and Hugh Gelabert, Vascular
urgery, University of California – Los Angeles, Los Angeles, Calif.
Objectives: Neurogenic Thoracic Outlet Syndrome (TOS) in ado-
escents is an uncommon condition where neurovascular compression
ay result in incapacitating symptoms. Teenage athletes may also have
heir academic and competitive careers placed in jeopardy. We have
eviewed our experience with neurogenic TOS in adolescents to better
efine the presentation, diagnosis, and results of surgical intervention.
Methods: A retrospective review of our database identified patients 19
ears of age and younger, presenting with neurogenic TOS who underwent
urgical decompression. Patient characteristics on presentation, preoperative
esting, surgical course, and follow-up data were all collected.
Results: From 1996 to 2009 a total of 20 patients (19 female, 1
ale) underwent surgery for neurogenic TOS. Twelve were student
thletes. Presenting symptoms included upper extremity paresthesia (n
9), pain (n  18), weakness (n  9), and hand atrophy (n  2).
ymptoms affected the dominant limb in 80% and were bilateral in 45%.
reoperative evaluation included a combination of anterior scalene mus-
le block (n  11) and electromyography or nerve conduction studies (n
16). Nonoperative therapy was attempted but failed in all. The surgical
pproach was a transaxillary first rib resection (TAFRR) in 19 and
ransaxillary scalene muscle resection (TASMR) in 1 patient. Intraoper-
tive findings included the presence of four cervical ribs, seven scalene
inimus muscles, and 4 patients had both. There were no perioperative
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Volume 54, Number 2 Abstracts 595or postoperative complications. The mean follow-up was 372 days. Six
patients required additional TASMR. Two patients underwent contralat-
eral TAFRR for neurogenic TOS. Overall, 18 patients had either com-
plete resolution or minimal residual symptoms. All patients were able to
return to school and 92% (11/12) of athletes were able to return to
competition.
Conclusions: Surgical treatment of neurogenic TOS in adolescents
may be performed with low morbidity. The majority of patients are female
and anatomic anomalies are commonly identified. Almost one third of
patients may require additional TASMR. Significant improvement in symp-
toms, the ability to return to school, and resumption of athletic competition
suggests that, in carefully selected adolescent patients, results may be supe-
rior to those reported in adults.
Hospital Volume of Thoracoabdominal Aneurysm Repair Does Not
Affect Mortality in California
Anna C. Weiss, MD, Amanda Green, Katherine E. Brown, MD, David
Chang, PhD, and Nikhil Kansal, MD, General Surgery, University of
California – San Diego, San Diego, Calif.
Objective: Current literature has shown that high volume institutions
have better outcomes after thoracoabdominal aneurysm repairs (TAARs).
The objective of this study was to investigate the morbidity and mortality
rates of TAAR in California. We hypothesized that the morbidity and
mortality rates have improved over the last 15 years, and that higher volume
institutions have significantly better outcomes.
Methods: We queried the California 100% discharge database for
patients who underwent TAAR between 1995 and 2008. We performed a
retrospective review comparing morbidity and mortality rates each year.
Morbidities included paraplegia, myocardial infarction, stroke, respiratory
failure, and renal failure. Two methods of classifying hospitals into low and
high volume cohorts were used: volume each year, or 3-year averages to
account for fluctuations. High volume was defined as more than eight
TAARs per year. An adjusted analysis was performed correcting for the
patient demographics, Charlson index, aneurysm rupture, and elective re-
pair.
Results: There were a total of 1085 TAARs between 1995 and 2008.
There were 117 low volume and four high-volume institutions. The mor-
bidity and mortality rates after TAAR did not significantly improve over time
(P  .3 and .25, respectively). On unadjusted analysis, the mortality rate at
1-year low volume institutions was 27%, compared to 20% at 1-year high-
volume institutions (P  .02). The mortality rate at 3-year averaged high-
volume institutions was 23%, compared to 25% at low-volume (P  .353).
Adjusted analysis revealed an odds ratio of mortality of 0.385 at 1-year
high-volume institutions (P  .053, 95% confidence interval [CI], .35-
1.01). Three-year averaged high-volume hospitals had an odds ratio of
mortality of 0.59 (P  .396; 95% CI, .175-1.99).
Conclusions: The morbidity and mortality rates after TAAR have not
significantly changed over the past 15 years in California. Although current
literature reports significantly better outcomes after TAAR at high-volume
institutions, in the state of California, the mortality after TAAR is similar at
both low-volume and high-volume institutions.
Optimal Method of Obtaining Aortic Measurements for Endovascular
Aneurysm Repair
Marlin Causey, Reagan Quan, Thomas Curry, and Niten Singh, Department
of Surgery Residency, Madigan Army Medical Center, Ft. Lewis, Wash.
Objective: Accurate preoperative planning and sizing for endovascular
aneurysm repair (EVAR) is essential for reduced procedural time, more
efficient utilization of fluoroscopy and contrast, and prevention of latter
adjunctive procedures. The current preoperative standard for EVAR is axial
computed tomography (CT), but other imaging modalities such as intravas-
cular ultrasound (IVUS), angiography, and CT reconstruction software
packages have also been used. Our objective was to determine which of the
above-mentioned imaging modalities is the optimal method of preoperative
planning for EVAR.
Methods: Data was collected prospectively over a 10-month period of
time on consecutive patients undergoing EVAR. Preoperatively, the sur-
geon of record obtained his measurements and calculations utilizing a
CT-reconstruction software package (RS Software) with centerline measure-
ments. Another surgeon, blinded to the case, obtained measurements and
calculations using standard axial CT. A standardized measurement protocol
was used. Both surgeons chose endografts based on their individual mea-
surements. Intraoperatively, IVUS and angiographic measurements were
obtained in a nonblinded fashion.
Results: Twenty EVARs were performed during the study period (3
women and 17 men) with a mean age of 72  5.5 years using an average
of 94.5 mL of contrast and 22 minutes of fluoroscopy. Aortic measure-
ments are listed in Table I comparing the different modalities. There was
no statistically significant difference in diameter measurement between
different modalities. However, centerline measurements from the RS
o
Pere significantly longer than either the CT or IVUS lengths and did
orrelate with the actual length and ultimately the graft used (Table II).
he ultimate endograft chosen correlated with the endograft in the RS
oftware in 15 of 17 patients while only 1 of 3 was sized appropriately
rom axial CT.
Conclusions: The ideal method to measure the aorta before deploy-
ent of an abdominal aortic endograft is evolving as technology im-
roves. We believe using reconstructive software of axial CTs allows for
ore accurate preoperative planning, particularly with the length of
rafts chosen.
able I. EVAR diameters at different levels
evel CT (mm) M2S (mm) IVUS (mm) P value
enal arteries 23.7  0.9 23.8  0.8 22.8  0.7 .731
mm 24.1  0.9 24.5  1.1 .986
0 mm 24.2  0.9 25.8  1.2 24.9  1.2 .921
5 mm 25.9  1.0 26.4  1.2 .811
0 mm 26.9  0.8 27.2  1.2 26.3  1.2 .812
ifurcation 23.0  1.1 24.9  1.7 22.8  1.5 .822
CIA seal 12.8  0.7 13.7  0.6 12.0  0.6 .272
CIA seal 13.0  0.8 12.3  0.4 11.7  0.6 .413
T, Computed tomography; IVUS, intravascular ultrasound; L CIA, left
ommon iliac artery; R CIA, right common iliac artery.
able II. Centerline measurements comparing different
odalities
enterline
easurements CT (mm) RS (mm)
Angiography
(mm)
P
value
orta to bifurcation 104  3.3 103  9.5 102  7.5 .812
orta to left
hypogastric 160  4.7 184  6.1 156  9.8 .019
orta to right
hypogastric 161  4.0 183  7.0 160  9.3 .012
T, Computed tomography.
ignificant Clinical Predictors of Postoperative Mortality Following
ndovascular Abdominal Aortic Aneurysm Repair
han-Vu Nguyen, MD, Linda Chun, MD, Clarence W. Cole, MD, and
evin Patel, MD, Kaiser Permanente-Los Angeles Medical Center, Los
ngeles, Calif.
Objectives: The purpose of this study was to show the relationships
etween endovascular aneurysm repair and the causes for long-term
ostoperative death in order to identify significant predictors of mortal-
ty.
Methods: A retrospective review of a multi-institution database of all
atients that underwent EVAR between May 2003 and June 2010 was
erformed. Comparisons of patient demographics and clinical characteristics
etween deceased and alive patients were evaluated.
Results: Five hundred eighty-eight patients (68 women and 520 men)
nderwent EVAR during the study period. There were a total of 82 deaths
13.9%). The causes of death were distributed as follows: 12 (14.6%), 6
7.3%), 25 (30.5%), 3 (3.7%), 7 (8.5%), and 29 (35.4%) in pulmonary,
ardiac, cancer, postoperation, other, and unknown, respectively. The aver-
ge age of patients was 77.8 7.8 years for those who died and 73.9 8.1
ears for those who were alive. Adjusting for all the other variables in the
odels, for each year increase in age, there was an 8% increase risk of death.
n addition, positive and significant relationships were found between age,
nd-stage renal disease (ESRD), chronic obstructive pulmonary disease
COPD), postoperative pulmonary event, and risk of all cause mortality.
atients with ESRD or COPD had approximately 4 and 2 times higher risk
f death compared to those without ESRD and COPD. There was a
rotective relationship between the patients on acetylsalicylic acid (ASA) or
reoperative statin and risk of all cause mortality. Those on an ASA or statin
efore operation were 50% and 46% less likely to die than those patients who
id not.
Conclusions: Patient age at time of EVAR and the presence of ESRD
r COPD were significant risk factors for long-term post repair mortality.
erioperative ASA and statin use were protective.
